Search

everythinglearnresearchcommunity

for

Search:↓

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Umbilical cord-derived media is safe and effective for hair growth.

Eclipta prostrata is a medicinal plant that helps treat diseases, protects the liver and nerves, and promotes hair growth.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Dengue virus can infect human hair follicle cells and may cause hair loss.

The regenerative medicine industry saw business growth with new partnerships, clinical trials, and financial investments.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Sarcoptes scabiei infection causes significant health and behavior changes in wombats.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Goat hair shows changes in metal levels and stress when goats move from indoors to mountain pastures.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Microbial biosurfactants could be a safer and environmentally friendly alternative to chemical surfactants in cosmetics.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.